Literature DB >> 30926166

A Disintegrin and Metalloproteinase 17 is required for ILC2 responses to IL-33.

Joseph C Lownik1, Daniel H Conrad2, Rebecca K Martin3.   

Abstract

Group 2 innate lymphoid cells (ILC2s) play an important role in the initiation of type-2 immune responses. Numerous targets have been identified that may activate or repress ILC2 function, though few negative regulatory feedback pathways induced upon activation have been shown to be operative in ILC2s. Here we demonstrate that loss of ADAM17 from ILC2s results in a selective defect in IL-33 responsiveness, but not IL-25 responsiveness. We find that IL1R2 is significantly upregulated at both the transcript and protein level in IL-33 activated ILC2s. We are also able to demonstrate that ADAM17 regulates IL1R2 levels on ILC2s in both a constitutive and activation induced manner. Additionally, IL1R2+ ILC2s, a unique subset of ILC2s, have decreased Il5 and Il13 transcripts following IL-33 stimulation. Overall, these data suggest that the expression of IL1R2 may act as an activation-induced negative regulatory feedback mechanism to decrease ILC2 responsiveness to IL-33.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADAM17; IL-33; IL1R2; ILC2

Mesh:

Substances:

Year:  2019        PMID: 30926166      PMCID: PMC6467721          DOI: 10.1016/j.bbrc.2019.03.120

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.

Authors:  Alissa A Chackerian; Elizabeth R Oldham; Erin E Murphy; Jochen Schmitz; Stefan Pflanz; Robert A Kastelein
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

2.  Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells.

Authors:  Kazuyo Moro; Taketo Yamada; Masanobu Tanabe; Tsutomu Takeuchi; Tomokatsu Ikawa; Hiroshi Kawamoto; Jun-Ichi Furusawa; Masashi Ohtani; Hideki Fujii; Shigeo Koyasu
Journal:  Nature       Date:  2009-12-20       Impact factor: 49.962

3.  The membrane form of the type II IL-1 receptor accounts for inhibitory function.

Authors:  D Neumann; C Kollewe; M U Martin; D Boraschi
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

Review 4.  The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer.

Authors:  Jessica Pruessmeyer; Andreas Ludwig
Journal:  Semin Cell Dev Biol       Date:  2008-09-18       Impact factor: 7.727

5.  Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity.

Authors:  Daniel R Neill; See Heng Wong; Agustin Bellosi; Robin J Flynn; Maria Daly; Theresa K A Langford; Christine Bucks; Colleen M Kane; Padraic G Fallon; Richard Pannell; Helen E Jolin; Andrew N J McKenzie
Journal:  Nature       Date:  2010-03-03       Impact factor: 49.962

6.  New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25.

Authors:  Stephen D Hurst; Tony Muchamuel; Daniel M Gorman; Jonathan M Gilbert; Theresa Clifford; Sylvia Kwan; Satish Menon; Brian Seymour; Craig Jackson; Ted T Kung; Joan K Brieland; Sandra M Zurawski; Richard W Chapman; Gerard Zurawski; Robert L Coffman
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

7.  Dynamic patterned expression of orphan nuclear receptor genes RORalpha and RORbeta in developing mouse forebrain.

Authors:  Yasushi Nakagawa; Dennis D M O'Leary
Journal:  Dev Neurosci       Date:  2003 Mar-Aug       Impact factor: 2.984

8.  The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II.

Authors:  Inken Lorenzen; Juliane Lokau; Stefan Düsterhöft; Ahmad Trad; Christoph Garbers; Jürgen Scheller; Stefan Rose-John; Joachim Grötzinger
Journal:  FEBS Lett       Date:  2012-03-21       Impact factor: 4.124

Review 9.  Immunological and inflammatory functions of the interleukin-1 family.

Authors:  Charles A Dinarello
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

10.  Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion.

Authors:  Padraic G Fallon; Sarah J Ballantyne; Niamh E Mangan; Jillian L Barlow; Ayan Dasvarma; Duncan R Hewett; Ann McIlgorm; Helen E Jolin; Andrew N J McKenzie
Journal:  J Exp Med       Date:  2006-04-10       Impact factor: 14.307

View more
  3 in total

1.  B cell ADAM17 controls T cell independent humoral immune responses through regulation of TACI and CD138.

Authors:  Joseph C Lownik; Jessica L Wimberly; Leila Takahashi-Ruiz; Rebecca K Martin
Journal:  Biochem Biophys Res Commun       Date:  2019-11-23       Impact factor: 3.575

2.  Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition.

Authors:  Genta Kakiyama; Dalila Marques; Rebecca Martin; Hajime Takei; Daniel Rodriguez-Agudo; Sandra A LaSalle; Taishi Hashiguchi; Xiaoying Liu; Richard Green; Sandra Erickson; Gregorio Gil; Michael Fuchs; Mitsuyoshi Suzuki; Tsuyoshi Murai; Hiroshi Nittono; Phillip B Hylemon; Huiping Zhou; William M Pandak
Journal:  J Lipid Res       Date:  2020-10-02       Impact factor: 5.922

Review 3.  Negative Regulation of the IL-1 System by IL-1R2 and IL-1R8: Relevance in Pathophysiology and Disease.

Authors:  Domenico Supino; Luna Minute; Andrea Mariancini; Federica Riva; Elena Magrini; Cecilia Garlanda
Journal:  Front Immunol       Date:  2022-02-08       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.